• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION VIGILANT X4 CRT-D; IMPLANTABLE DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION VIGILANT X4 CRT-D; IMPLANTABLE DEVICE Back to Search Results
Model Number G247
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Unspecified Infection (1930)
Event Date 10/09/2023
Event Type  Injury  
Manufacturer Narrative
The product has been received for analysis.Upon completion of the failure analysis of the complaint product, if there is any further relevant information from that review, a supplemental report will be filed.
 
Event Description
It was reported that the patient with this cardiac resynchronization therapy defibrillator (crt-d) had exhibited infection and hematoma.A revision was performed and the crt-d along with the right ventricular (rv) lead, right atrial (ra) lead, left ventricular (lv) lead and previously capped rv lead were explanted.No additional adverse patient effects were reported.This crt-d will be returned for analysis.
 
Event Description
It was reported that the patient with this cardiac resynchronization therapy defibrillator (crt-d) had exhibited infection and hematoma.A revision was performed and the crt-d along with the right ventricular (rv) lead, right atrial (ra) lead, left ventricular (lv) lead and previously capped rv lead were explanted.No additional adverse patient effects were reported.This crt-d will be returned for analysis.
 
Manufacturer Narrative
The product has been received for analysis.Upon completion of the failure analysis of the complaint product, if there is any further relevant information from that review, a supplemental report will be filed.The returned device was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.The device was successfully interrogated and completed a memory dump.Visual inspection found no irregularities with the device, and the header was firmly attached.The longevity calculation for this device passed or was not applicable.The infection or infection related allegation could not be confirmed by laboratory analysis.Infection is a known medical risk when the skin barrier is breached.Analysis of the returned product is not able to provide relevant information for infection-related allegations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIGILANT X4 CRT-D
Type of Device
IMPLANTABLE DEVICE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key18044283
MDR Text Key327016777
Report Number2124215-2023-60880
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526589287
UDI-Public00802526589287
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberG247
Device Catalogue NumberG247
Device Lot Number314221
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/17/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/31/2023
Supplement Dates Manufacturer Received12/21/2023
Supplement Dates FDA Received01/11/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/03/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age77 YR
Patient SexFemale
-
-